Brain Development Research Program

Sponsor
University of California, San Francisco (Other)
Overall Status
Recruiting
CT.gov ID
NCT00305305
Collaborator
University of Washington (Other), California Institute of Technology (Other)
2,000
1
257.1
7.8

Study Details

Study Description

Brief Summary

Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    We are studying both the genetics and clinical features of these disorders. We hope to understand the problems faced by individuals with these disorders as well as their causes. In the future, we hope to develop therapies that are geared specifically for individuals based on the underlying biology. To participate in the study, you will be asked to provide a copy of the magnetic resonance imaging (MRI) documenting Agenesis Corpus Callosum (ACC), Polymicrogyria (PMG), or Dandy-Walker malformation (DWM), clinical information, and saliva or blood samples from the affected individual and from the parents. Please see contact information and our webpage below.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Disorders of Cerebral Development: A Phenotypic and Genetic Analysis
    Study Start Date :
    Aug 1, 2003
    Anticipated Primary Completion Date :
    Jan 1, 2025
    Anticipated Study Completion Date :
    Jan 1, 2025

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Clinical diagnosis of agenesis or dysgenesis of the corpus callosum, polymicrogyria, or Dandy-Walker malformation

      • Should be confirmed by an MRI (Magnetic Resonance Imaging) of the brain

      Exclusion Criteria:
      • Fully formed but hypoplastic corpus callosum

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University of California, San francisco San Francisco California United States 94143

      Sponsors and Collaborators

      • University of California, San Francisco
      • University of Washington
      • California Institute of Technology

      Investigators

      • Principal Investigator: Elliott H Sherr, MD, PhD, University of California, San Francisco
      • Principal Investigator: James Barkovich, MD, University of California, San Francisco
      • Principal Investigator: Pratik Mukherjee, MD, PhD, University of California, San Francisco

      Study Documents (Full-Text)

      None provided.

      More Information

      Additional Information:

      Publications

      Responsible Party:
      University of California, San Francisco
      ClinicalTrials.gov Identifier:
      NCT00305305
      Other Study ID Numbers:
      • UCSF-PCRC #2206
      First Posted:
      Mar 21, 2006
      Last Update Posted:
      Aug 5, 2022
      Last Verified:
      Aug 1, 2022

      Study Results

      No Results Posted as of Aug 5, 2022